Company / Return on Assets (ROA)
Syndax Pharmaceuticals Inc Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-53.9%
FY2025
5-year range
-53.9% / -12.5%
FY2021-FY2025
Trend
-22.5%
vs FY2024
Sector context
#183 of 213
Health Care
What the data says
Syndax Pharmaceuticals Inc's return on assets (roa) of -53.9% is lower than 86% of companies in the Health Care sector (FY2025). Return on Assets (ROA) has declined for 4 consecutive years, from -12.5% in FY2021 to -53.9% in FY2025.
Based on SEC 10-K filings.
-53.9% in FY2025 with a 5-year CAGR of -29.3%.
Declined from -34.2% to -53.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -23.8pp
- 5-Year Change
- -29.3pp
- 10-Year Change
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 213This company -53.9% Sector average -24.1%
▼
-123.2% below sector average
Key checks
Key Insights
- Syndax Pharmaceuticals Inc's return on assets (roa) has declined for 4 consecutive years.
- In FY2025, return on assets (roa) decreased 22.5% year-over-year.
- Currently 29.7pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -53.9% | -22.5% |
| FY2024 | -44.0% | -28.7% |
| FY2023 | -34.2% | -13.8% |
| FY2022 | -30.0% | -141.0% |
| FY2021 | -12.5% | +49.3% |
| FY2020 | -24.6% | +74.3% |
| FY2019 | -95.7% | -80.7% |
| FY2018 | -53.0% | -201.4% |
| FY2017 | -17.6% | +3.4% |
| FY2016 | -18.2% | +32.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026